Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Issue Sixty-Two – December 2012 standards of C.A.R.E. CLINICAL CASE MANAGEMENT NEWSLETTER The Calgary Animal Referral & Emergency Centre Animal Hospital standards of C.A.R.E. Issue Sixty-Two – December 2012 Pericardial Effusion: Diagnosis and Stabilization John Murray, DVM Pericardial effusion is an abnormal accumulation of fluid within the pericardial sac. There are a multitude of differential diagnoses for this condition, including neoplastic, infectious, metabolic, toxic, cardiovascular, traumatic, and idiopathic. Regardless of the cause, the hemodynamic consequences of pericardial effusion can range from relatively mild or nonexistent (if the pericardium has expanded; typically only occurs with chronic effusions) to severe and life-threatening. In the latter scenario, there is a marked increase in intrapericardial pressure resulting in greatly decreased ventricular filling during diastole (cardiac tamponade). This in turn results in decreased cardiac output and hypotension. Death can occur if the pericardial effusion is not resolved, making rapid diagnosis and treatment of this condition critical to case management. For neoplastic and idiopathic pericardial effusions, the typical signalment is older large breed dogs, though these conditions do occur in small breed dogs as well. Toxic, infectious, and traumatic pericardial effusions can occur in any breed, sex, or age of cat or dog. Cats or dogs with congestive heart failure may have a relatively insignificant degree of pericardial effusion. Older small breed dogs with severe degenerative mitral valve disease may experience left atrial rupture and subsequent pericardial effusion. Historical complaints are similar to those seen with right-sided heart failure, including lethargy, anorexia, syncope, weakness, vomiting, dyspnea, and exercise intolerance. Abdominal distension may occur due to ascites and hepatic congestion. Common physical examination findings include muffled heart sounds, weak femoral pulses / arterial hypotension, sinus tachycardia, pale mucus membranes, and jugular venous distension. Pulsus paradoxus (an exaggerated decline greater than 10 mm Hg in systemic arterial pressure during inspiration) is highly suggestive of cardiac tamponade and can be detected on palpation of femoral pulse quality. Though pericardial effusion can be highly suspected based on historical and physical examination findings, additional diagnostics are required to confirm the diagnosis. Thoracic radiographs will typically reveal an enlarged and globoid cardiac silhouette. However, with peracute and small volume pericardial effusions, the degree of change seen may be mild and the diagnosis may be uncertain. Elevation of the trachea and distension of the caudal vena cava may also be seen. Pleural effusion may be seen and can obscure the cardiac silhouette, making the diagnosis difficult. Electrocardiography may reveal ventricular or supraventricular arrhythmias, in addition to sinus tachycardia. If present, electrical alternans (beat-to-beat variations in the contour and amplitude of the QRS complex, ST segment, and T wave) is highly suggestive of pericardial effusion. However, this is only seen in a small number of cases. With relatively little training, echocardiography can be used to confirm the diagnosis of www.carecentre.ca facebook.com/CARECentre p.1 standards of C.A.R.E. Issue Sixty-Two – December 2012 pericardial effusion by identifying a hypoechoic or anechoic space between the epicardium and pericardium. The lack of readily available ultrasound should not preclude therapeutic intervention in the form of pericardiocentesis and other supportive measures if the patient is unstable and pericardial effusion is suspected. Intravenous crystalloid fluids can be used to improve diastolic filling and help alleviate a shock state if indicated. Fluids must be used judiciously and with careful monitoring as patients may not tolerate excessive volumes of IV fluids. It is important that pericardial effusion not be confused with heart failure, as the use of arterial or venodilators, diuretics, or positive inotropes may be harmful. Pericardiocentesis is necessary to relieve the state of cardiac tamponade. Light sedation may be necessary to perform the pericardiocentesis safely. Opiates (eg. butorphanol) with or without a benzodiazepine are the safest choices as they have minimal cardiovascular side effects. In more severely compromised patients, local anesthesia including the skin, intercostal musculature, and parietal pleura at the intended site of pericardiocentesis may be sufficient. The procedure is performed with the patient in either left lateral or sternal recumbency. The right thorax is clipped and aseptically prepared from the second to eighth intercostal space. Pericardiocentesis is performed at either the fourth or fifth intercostal space, cranial to the rib to avoid lacerating the intercostal vasculature. A 22g (cat) or up to 14g IV catheter (large dog) of appropriate length is selected. The catheter is slowly advanced into the pericardium until fluid is retrieved, at which point the catheter is advanced over the needle and into the pericardial space. The catheter is then connected to a closed collection system and fluid slowly withdrawn. A needle can be used instead of a catheter, but may be associated with greater risk of cardiac puncture. The character of the fluid is often hemorrhagic, however it can certainly vary. Samples of the fluid should be collected for later analysis. If pleural effusion is present secondary to cardiac tamponade, this fluid will be encountered before entering the pericardial space and will typically appear grossly as a transudate or modified transudate. The catheter will need to be advanced further until a more characteristic pericardial effusion is retrieved. If uncertain, then fluid can be withdrawn and the patient monitored for clinical improvement. Sinus tachycardia will typically improve at least to some degree with removal of the pericardial fluid. If a clinical improvement is not appreciated, then the fluid being collected is likely pleural. When performed carefully, serious complications associated with pericardiocentesis are rare. Electrocardiographic monitoring is ideally available during pericardiocentesis as arrhythmias may be noted if the catheter is advanced too far and contacts the heart. Arrhythmias will typically resolve if the catheter is withdrawn. If not, then appropriate medical intervention should be considered. As with ultrasound, the lack of available ECG monitoring should not preclude pericardiocentesis in a patient that is severely unstable as death may be imminent. Cardiac puncture may occur if the catheter is inadvertently advanced into the heart. In most instances of cardiac puncture, the hemorrhagic fluid collected will be seen to clot. Typically, pericardial effusion will not clot after collection, even when hemorrhagic in nature. However, in the event of peracute or active hemorrhage into the pericardial space, the pericardial fluid www.carecentre.ca facebook.com/CARECentre p.2 standards of C.A.R.E. Issue Sixty-Two – December 2012 may still clot after collection. If cardiac puncture is suspected, then the catheter should be withdrawn. Further and potentially significant hemorrhage into the pericardial space may occur if a tumor or coronary sinus is lacerated. Signs of shock and right sided heart failure typically improve rapidly after pericardiocentesis is performed and cardiac tamponade resolved. In the case of hemorrhagic pericardial effusions, the patient may be anemic and clinical signs related to anemia or hemorrhage may persist. Depending on the etiology, recurrence of pericardial effusion and cardiac tamponade may occur rapidly and continued patient monitoring is recommended. Once the patient is stabilized, further diagnostic evaluation is necessary to determine the etiology of the pericardial effusion. Echocardiography is useful to evaluate for a neoplastic source. Submission of pericardial fluid for cytology and culture may be beneficial. Cytology alone cannot rule out a neoplastic cause for the effusion, as neoplastic cells may not exfoliate and even if they do they may be difficult to identify within a vastly hemorrhagic effusion. A coagulation profile should be performed if a coagulopathy is suspected. Pericardial effusion secondary to uremia or cholesterol-based pericardial effusion associated with hypothyroidism can be ruled in or out with basic bloodwork. Idiopathic pericardial effusion is a diagnosis of exclusion. This can be a difficult diagnosis to make, as the lack of a visible tumor on echocardiography does not definitively exclude the possibility of a neoplastic cause for the effusion. In summary, a number of inciting causes may result in pericardial effusion. The severity of clinical signs can vary greatly depending on the magnitude of the increase in intrapericardial pressure and presence of cardiac tamponade. A diagnosis of pericardial effusion can be highly suspected based on historical and physical examination findings, as well as readily available diagnostics such as thoracic radiography. Even in the absence of confirmed pericardial effusion on echocardiography, life-saving pericardiocentesis can be performed with relatively little risk if pericardial effusion is suspected and the patient is in critical condition. www.carecentre.ca facebook.com/CARECentre p.3